Natural killer activity in thyroid cancer patients. 1987

P Boros, and G Balázs, and G Szegedi
Third Department of Medicine, Debrecen University Medical School, Hungary.

The natural killer activity of thyroid cancer patients has been studied. The cytotoxic capacity was found to be elevated in tumourless patients and in cases of highly differentiated histologic type compared to the results of patients with metastasis or anaplastic tumour. The values of patients in the progressive phase of the disease were significantly worse compared to the healthy controls. No connection was found between the natural killer activity and the time elapsed since the operation.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013964 Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. Cancer of Thyroid,Thyroid Cancer,Cancer of the Thyroid,Neoplasms, Thyroid,Thyroid Adenoma,Thyroid Carcinoma,Adenoma, Thyroid,Adenomas, Thyroid,Cancer, Thyroid,Cancers, Thyroid,Carcinoma, Thyroid,Carcinomas, Thyroid,Neoplasm, Thyroid,Thyroid Adenomas,Thyroid Cancers,Thyroid Carcinomas,Thyroid Neoplasm

Related Publications

P Boros, and G Balázs, and G Szegedi
August 1983, Nihon Gan Chiryo Gakkai shi,
P Boros, and G Balázs, and G Szegedi
December 1987, Chest,
P Boros, and G Balázs, and G Szegedi
January 1990, European journal of gynaecological oncology,
P Boros, and G Balázs, and G Szegedi
January 1987, Cancer investigation,
P Boros, and G Balázs, and G Szegedi
January 1987, European urology,
P Boros, and G Balázs, and G Szegedi
November 1983, The Indian journal of medical research,
P Boros, and G Balázs, and G Szegedi
January 1990, Cancer immunology, immunotherapy : CII,
P Boros, and G Balázs, and G Szegedi
January 1992, Autoimmunity,
P Boros, and G Balázs, and G Szegedi
January 1989, Immunopharmacology,
P Boros, and G Balázs, and G Szegedi
January 1988, Voprosy virusologii,
Copied contents to your clipboard!